Health Services Research
Latest posts by Health Services Research (see all)
- Why We Should Not Be Indifferent to Specification Choices for Difference-in-Differences - Dec. 11, 2014
- Variations in Guideline-Concordant Breast Cancer Adjuvant Therapy in Rural Georgia - Dec. 10, 2014
- Drivers of Inpatient Hospital Experience Using the HCAHPS Survey in a Canadian Setting - Dec. 08, 2014
- Spillover Effects of the Affordable Care Act? Exploring the Impact on Young Adult Dental… - Dec. 08, 2014
Background Assessing the real-world comparative effectiveness of common interventions is challenged by unmeasured confounding. Objective To determine whether the mortality benefit shown for drug-eluting stents (DES) over bare metal stents (BMS) in observational studies persists after controls for/tests for confounding. Data Sources/Study Setting Retrospective observational study involving 38,019 patients, 65 years or older admitted for an index percutaneous coronary intervention receiving DES or BMS in Pennsylvania in 2004–2005 followed up for death through 3 years. Study Design Analysis was at the patient level.